Cases & Deals

Funds managed by Invesco invest in Cell Medica

Clients Invesco Asset Management Limited

Jones Day advised Invesco Asset Management in connection with the purchase by its discretionary managed funds of Series C Convertible Preferred Stock in a private placement by Cell Medica, a leading cellular immunotherapy company. Touchstone Innovations and funds managed by Woodford Investment Management acted as co-investors in the investment round.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.